Drug intelligence / Profile preview

cordycepin triphosphate

Development stage
Unknown
Modality
Small Molecules
01

Overview

Cordycepin triphosphate is the triphosphorylated form of cordycepin (3’-deoxyadenosine), a purine nucleoside analog derived from the fungus Cordyceps militaris. It is a purine ribonucleoside 5′-triphosphate and acts as an antimetabolite with antifungal, antineoplastic, antiviral, and immunomodulatory properties[2][9]. Mechanistically, cordycepin triphosphate mimics adenosine triphosphate (ATP) due to its structural similarity and can be incorporated into RNA by cellular enzymes in place of ATP. This incorporation disrupts normal RNA synthesis by inhibiting polyadenylation and acting as an RNA elongation inhibitor[2][5]. It also inhibits mTOR signaling via activation of AMP-activated protein kinase (AMPK), leading to reduced cell proliferation and induction of apoptosis in tumor cells[2][5]. The compound has been used experimentally as a transcriptional inhibitor in molecular biology assays[3], but it is not approved for clinical use.

Other names
3'-deoxyadenosine 5'-triphosphate3'-dATP3'-deoxy-ATPCordycepin 5'-triphosphate
02

Targets

PRKAA1 (AMP-activated protein kinase alpha catalytic subunit isoform alpha-1)mTOR (Mammalian target of rapamycin kinase)AC (Adenylyl cyclase family)

Beyond the preview

Go deeper on cordycepin triphosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cordycepin triphosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call